RIPERN Endorsement to be phased out

Published: 11 November 2021  

  
On Friday 5 November, the Nursing and Midwifery Board of Australia (NMBA) advised that the RIPERN Endorsement is being phased out. If you hold this endorsement (for scheduled medicines for registered nurses – rural and isolated practice), you would also have received an email from NMBA. 

The NMBA has been working closely with the two states that currently rely on the RIPERN endorsement within their legislative frameworks (Victoria and Queensland). These states have now finalised alternative regulatory mechanisms for RNs to obtain, supply and administer certain scheduled medicines in rural and isolated practice settings.

Importantly, the day-to-day practice of RNs who hold the RIPERN endorsement and the delivery of related healthcare services for rural and regional Australian communities will remain unchanged. 

When will the endorsement be phased out? 

A new regulatory framework for medicines came into effect in Queensland in September 2021 and it is expected that the finalised Victorian framework will come into effect in early 2022. Once the Victorian change takes effect, the NMBA will write to Health Ministers requesting that the RIPERN endorsement is retired. 

Changes for RIPERN RNs who practice in Queensland

Queensland’s new medicines and poisons regulatory framework came into effect in September 2021. This framework enables rural and isolated practice RNs to continue to obtain, supply and administer certain medicines via an extended practice authority. The day-to-day practice of Queensland RNs who hold the RIPERN endorsement will remain unchanged. For further information, you can access the relevant Queensland Health publication here.

For more information, visit the NMBA website, or read the fact sheet .